Patents by Inventor Matthias Mag

Matthias Mag has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6348312
    Abstract: The invention relates to novel stabilized oligonucleotides in which at least one non-terminal pyrimidine nucleoside is modified, and to their use as a diagnostic or pharamaceutical for the treatment of viral infections, cancer or diseases in which integrins or cell-cell adhesion receptors are active.
    Type: Grant
    Filed: November 10, 1994
    Date of Patent: February 19, 2002
    Assignee: Hoescht Aktiengesellschaft
    Inventors: Anuschirwan Peyman, Eugen Uhlmann, Matthias Mag, Gerhard Kretzschmar, Matthias Helsberg, Irvin Winkler
  • Patent number: 6121349
    Abstract: Aqueous dispersions of carboxyl-containing polyvinyl acetals which contain no emulsifiers, no readily volatile organic solvents and no nonvolatile plasticizers, preparable by a) reacting hydroxyl-containing polyvinyl acetals with polycarboxylic anhydrides in the melt or in high-boiling solvents, b) neutralizing at least some of the carboxylic acid groups present in the resulting modified polyvinyl acetals, and c) dispersing the resulting salt of the modified polyvinyl acetals in water, are suitable as coating compositions for paper and textiles and as binders for paints and varnishes.
    Type: Grant
    Filed: September 25, 1997
    Date of Patent: September 19, 2000
    Assignee: Clariant GmbH
    Inventors: Hannes Fischer, Matthias Mag
  • Patent number: 5679785
    Abstract: 3'-(2')-Amino- or thiol-modified, fluorescent dye-coupled nucleosides, nucleotides and oligonucleotides, and a process for the preparation and the use thereofThe OH group located in the 3' and/or 2' position of a nucleoside, nucleotide or oligonucleotide is derivatized to an amino or thiol group and subsequently a fluorescent dye is coupled thereto. The resulting 3'- and/or 2'-amino- and thiol-modified nucleosides, nucleotides and oligonucleotides can then be used for the synthesis of complementary strands in the presence of a template strand or of oligonucleotides and for the detection of genetic material.
    Type: Grant
    Filed: January 18, 1994
    Date of Patent: October 21, 1997
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Joachim Engels, Mathias Herrlein, Renate Konrad, Matthias Mag
  • Patent number: 5668269
    Abstract: 3'-(2')-Amino- or thiol-modified, fluorescent dye-coupled nucleosides, nucleotides and oligonucleotides, and a process for the preparation and the use thereof.The OH group located in the 3' and/or 2' position of a nucleoside, nucleotide or oligonucleotide is derivatized to an amino or thiol group and subsequently a fluorescent dye is coupled thereto. The resulting 3'- and/or 2'-amino- and thiol-modified nucleosides, nucleotides and oligonucleotides can then be used for the synthesis of complementary strands in the presence of a template strand or of oligonucleotides and for the detection of genetic material.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: September 16, 1997
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Joachim Engels, Mathias Herrlein, Renate Konrad, Matthias Mag
  • Patent number: 5659025
    Abstract: The OH group located in the 3' and/or 2' position of a nucleoside, nucleotide or oligonucleotide is derivatized to an amino or thiol group and subsequently a fluorescent dye is coupled thereto. The resulting 3'- and/or 2'-amino- and thiol-modified nucleosides, nucleotides and oligonucleotides can then be used for the synthesis of complementary strands in the presence of a template strand or of oligonucleotides and for the detection of genetic material. They have the advantage that the fluorescent label need no longer be attached to the 5' end of the oligonucleotide or to the nucleobase, and thus need not be introduced during the chemical synthesis as in labeling techniques hitherto known, while the known and conventional methods have the disadvantage that only a few polymerases can be employed for the synthesis, the acceptance of the triphosphates by the polymerases diminishes and, moreover, a large substrate excess is necessary.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: August 19, 1997
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Joachim Engels, Mathias Herrlein, Renate Konrad, Matthias Mag
  • Patent number: 5563050
    Abstract: The invention relates to novel antisense oligonucleotides having the sequences ##STR1## and their mixtures, homologs or modified forms, against HSV 1.
    Type: Grant
    Filed: July 27, 1994
    Date of Patent: October 8, 1996
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Anuschirwan Peyman, Eugen Uhlmann, Matthias Mag, Gerhard Kretzschmar, Matthias Helsberg, Irvin Winkler